Pfizer on Thursday reported third-quarter earnings and revenue that topped estimates and hiked its full-year profit guidance, as cost cuts helped to outweigh declining sales for the period fell.Here's what the company reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:Earnings per share: 87 cents adjusted vs. 63 cents expectedRevenue: $16.65 billion vs. $16.58 billion expectedThe results come weeks after Pfizer became the first drugmaker to str ...